Cafepharma Today

January 2 2025 - 10 clinical trials to watch in the first half of 2025
10 clinical trials to watch in the first half of 2025
FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024
Trump tariffs and drug prices
Neumora laid low by depression trial failure
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Pfizer Goes Generic
WSJ Online
Friday, October 17, 2008 - 9:03am
tags:
Boston Scientic Upped to a Buy
Yahoo/Zacks.com
Friday, October 17, 2008 - 9:03am
tags:
Abbott Labs A Salve For The Wounded Portfolio
Investopedia
Friday, October 17, 2008 - 9:02am
tags:
Abbott Labs Shows Earnings Strength
Yahoo/Zacks.com
Thursday, October 16, 2008 - 9:56am
tags:
Cell Genesys cutting 75 percent of its work force after ending prostate cancer program
Yahoo/AP
Thursday, October 16, 2008 - 9:39am
tags:
The biotech market share report
Fierce Biotech
Thursday, October 16, 2008 - 9:28am
tags:
Elan shareholders file lawsuit
Fierce Biotech
Thursday, October 16, 2008 - 9:27am
tags:
Genentech on Roche's Plans: Our Lips Are Sealed
Seeking Alpha
Thursday, October 16, 2008 - 9:22am
tags:
Genentech Investors Monitor Avastin Study
The Street.com
Thursday, October 16, 2008 - 9:21am
tags:
Genzyme seeks to treat Fabry disease earlier
Bizjournals.com
Thursday, October 16, 2008 - 9:21am
tags:
Eye allergy treatment Elestat receives new patent offering protection until 2020
Yahoo/AP
Thursday, October 16, 2008 - 9:19am
tags:
Teva to sell veterinary line to Phibro Animal Health
Marketwatch
Thursday, October 16, 2008 - 9:19am
tags:
New Remedies to Treat Blood Clots Are Near
WSJ Online
Thursday, October 16, 2008 - 9:04am
tags:
Investors Unimpressed By Abbott
Forbes
Thursday, October 16, 2008 - 9:03am
tags:
Wyeth postpones pursuing European approval for Pristiq as it conducts additional studies
Yahoo/AP
Thursday, October 16, 2008 - 9:02am
tags:
Pharma Not as Fazed by Wall Street Turmoil
PharmExec
Thursday, October 16, 2008 - 8:55am
tags:
For Lilly CEO John Lechleiter, risky deals are part of the job
Indianapolis Star, IN
Thursday, October 16, 2008 - 8:54am
tags:
Baxter Profit Rises 19%, Led By Blood Treatments
Bloomberg
Thursday, October 16, 2008 - 8:43am
tags:
Is FDA Watching YouTube?
PharmExec
Thursday, October 16, 2008 - 8:41am
tags:
Wyeth Provides Regulatory Update Regarding Desvenlafaxine for the Treatment of Major Depressive Disorder
Yahoo
Wednesday, October 15, 2008 - 10:25am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Recipe Blogging: Varieties of Pickles
In the Pipeline
Targeted Cancer Drugs, Succeeding and Failing
In the Pipeline
Drugs Inside Cells - A Bit of Light
In the Pipeline
HPV Infections: Friend and Foe
In the Pipeline
Drug Channels News Roundup, December 2024: Crazy Medicare Reimbursements, Independents Grow (Really!), AFP Risks, Pharmacy History, GLP-1 Jokes, and Two Cool Dudes
Drug Channels
Ripping Through The Crystal
In the Pipeline
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts (rerun)
Drug Channels
Real High Throughput Chemistry Through Mass Spec
In the Pipeline
White Bagging Update 2024: Providers’ Pushback Preserves Buy-and-Bill (rerun)
Drug Channels

Latest Jobs

EP Senior Mapping Specialist - Bay Area, CA
San Francisco, California, 94199
Boston Scientific Gruppe
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia,
Otsuka
Sr. Training Manager, Learning & Performance
Yardley, Pennsylvania, 19067
EVERSANA
Area Manager, Immunology West Central Tulsa
Coffeyville, Kansas, 67337
CSL Behring
staff - Registered Nurse (RN) - Clinical Liaison - $80K-90K per year
Houston, Texas, 77246
AccentCare
Pharmaceutical Sales Customer Engagement - Kalamazoo, MI
Michigan, ,
Otsuka
Pharmaceutical Sales Customer Engagement - Wilmington, NC
North Carolina, ,
Otsuka
Pharmaceutical Sales Customer Engagement- Valparaiso, IN
Valparaiso, Indiana,
Otsuka
Area Manager-Specialty Northeast, Albany
Fields, Oregon, 97710
CSL Behring
Pharmaceutical Sales Customer Engagement - Atlanta S, GA
Atlanta, Georgia,
Otsuka
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information